Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_10137 details
Primary information
SALIDSAL_10137
Biomarker nameMonocyte chemoattractant protein-1
Biomarker TypeNA
Sampling MethodTwenty four patients with SLE (all women) and 5 controls.
Collection MethodAn average 2 ml of unstimulated whole saliva was collected.
Analysis Methodtwo stochastic sensors based on metal nanocomposites-graphene pastes
Collection SiteWhole Saliva
Disease CategoryAutoimmune Disorder
Disease/ConditionSystemic lupus erythematosus
Disease SubtypeNA
Fold Change/ ConcentrationNA
Up/DownregulatedNA
ExosomalNA
OrganismHomo sapiens
PMID29621567
Year of Publication2018
Biomarker IDP13500
Biomarker CategoryProtein
SequenceMKVSAALLCLLLIAATFIPQGLAQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT
Title of studySalivary biomarkers of inflammation in systemic lupus erythematosus
Abstract of studySaliva is currently used as a reliable diagnostic fluid in a wide range of local and systemic diseases. However, the link between salivary diagnosis and the inflammatory process in autoimmune diseases has not yet been explored. The aim of our study is to assess possible correlations between salivary inflammatory markers and systemic lupus erythematosus (SLE). Patients fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) diagnosis criteria were included. Salivary and serum levels of interleukin-6 (IL-6), leptin, monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) were determined using stochastic sensors. Serum leptin and IL-6 had significantly higher levels in SLE patients compared to non-SLE. Also, salivary IL-6 levels highly correlated with the serum IL-6 levels. A positive correlation was found between salivary and serum levels of IL-6, signaling salivary IL-6 as a reliable marker for assessing the inflammation process in SLE.